Cargando…

Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG

BACKGROUND: The associations of metabolic syndrome (MetS) or diabetes mellitus (DM) on long-term survival after coronary artery bypass grafting (CABG) have not been extensively evaluated. The aim of the present study was to assess the impact of MetS and DM on the 16-year survival after CABG. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Hällberg, Ville, Palomäki, Ari, Lahtela, Jorma, Voutilainen, Seppo, Tarkka, Matti, Kataja, Matti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914357/
https://www.ncbi.nlm.nih.gov/pubmed/24447406
http://dx.doi.org/10.1186/1475-2840-13-25
_version_ 1782302392090361856
author Hällberg, Ville
Palomäki, Ari
Lahtela, Jorma
Voutilainen, Seppo
Tarkka, Matti
Kataja, Matti
author_facet Hällberg, Ville
Palomäki, Ari
Lahtela, Jorma
Voutilainen, Seppo
Tarkka, Matti
Kataja, Matti
author_sort Hällberg, Ville
collection PubMed
description BACKGROUND: The associations of metabolic syndrome (MetS) or diabetes mellitus (DM) on long-term survival after coronary artery bypass grafting (CABG) have not been extensively evaluated. The aim of the present study was to assess the impact of MetS and DM on the 16-year survival after CABG. METHODS: Diabetic and metabolic status together with relevant cardiovascular data was established in 910 CABG patients operated in 1993-94. They were divided in three groups as follows: neither DM nor MetS (375 patients), MetS alone (279 patients) and DM with or without MetS (256 patients). The 16-year follow-up of patient survival was carried out using national health databases. The relative survival rates were analyzed using the Life Table method comparing the observed survival rates of three patient groups to the rates based on age-, sex- and time-specific life tables for the whole population in Finland. To study the independent significance of MetS and DM for clinical outcome, multivariate analysis was made using an optimizing stepwise procedure based on the Bayesian approach. RESULTS: Bayesian multivariate analysis revealed together six variables to predict clinical outcome (2 months to 16 years) in relation to the national background population, i.e. age, diabetes, left ventricular ejection fraction, BMI, perfusion time during the CABG and peripheral arterial disease. Our principal finding was that after postoperative period the 16-year prognosis of patients with neither DM nor MetS was better than that of the age-, sex-and time-matched background population (relative survival against background population 1.037, p < 0.0001). The overall survival of MetS patients resembled that of the matched background population (relative survival 0.998, NS). DM was associated with significantly increased mortality (relative survival 0.86, p < 0.0001). Additionally, mortality was even higher in patients receiving insulin treatment than in those without. Excess death rate of DM patients was predominantly caused by cardiovascular causes. CONCLUSION: In this long-term follow-up study patient groups without diabetes had at least equal 16 years’ survival after CABG than their matched background populations. Survival of DM patients started to deteriorate already few years after the operation.
format Online
Article
Text
id pubmed-3914357
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39143572014-02-06 Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG Hällberg, Ville Palomäki, Ari Lahtela, Jorma Voutilainen, Seppo Tarkka, Matti Kataja, Matti Cardiovasc Diabetol Original Investigation BACKGROUND: The associations of metabolic syndrome (MetS) or diabetes mellitus (DM) on long-term survival after coronary artery bypass grafting (CABG) have not been extensively evaluated. The aim of the present study was to assess the impact of MetS and DM on the 16-year survival after CABG. METHODS: Diabetic and metabolic status together with relevant cardiovascular data was established in 910 CABG patients operated in 1993-94. They were divided in three groups as follows: neither DM nor MetS (375 patients), MetS alone (279 patients) and DM with or without MetS (256 patients). The 16-year follow-up of patient survival was carried out using national health databases. The relative survival rates were analyzed using the Life Table method comparing the observed survival rates of three patient groups to the rates based on age-, sex- and time-specific life tables for the whole population in Finland. To study the independent significance of MetS and DM for clinical outcome, multivariate analysis was made using an optimizing stepwise procedure based on the Bayesian approach. RESULTS: Bayesian multivariate analysis revealed together six variables to predict clinical outcome (2 months to 16 years) in relation to the national background population, i.e. age, diabetes, left ventricular ejection fraction, BMI, perfusion time during the CABG and peripheral arterial disease. Our principal finding was that after postoperative period the 16-year prognosis of patients with neither DM nor MetS was better than that of the age-, sex-and time-matched background population (relative survival against background population 1.037, p < 0.0001). The overall survival of MetS patients resembled that of the matched background population (relative survival 0.998, NS). DM was associated with significantly increased mortality (relative survival 0.86, p < 0.0001). Additionally, mortality was even higher in patients receiving insulin treatment than in those without. Excess death rate of DM patients was predominantly caused by cardiovascular causes. CONCLUSION: In this long-term follow-up study patient groups without diabetes had at least equal 16 years’ survival after CABG than their matched background populations. Survival of DM patients started to deteriorate already few years after the operation. BioMed Central 2014-01-22 /pmc/articles/PMC3914357/ /pubmed/24447406 http://dx.doi.org/10.1186/1475-2840-13-25 Text en Copyright © 2014 Hällberg et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Investigation
Hällberg, Ville
Palomäki, Ari
Lahtela, Jorma
Voutilainen, Seppo
Tarkka, Matti
Kataja, Matti
Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG
title Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG
title_full Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG
title_fullStr Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG
title_full_unstemmed Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG
title_short Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG
title_sort associations of metabolic syndrome and diabetes mellitus with 16-year survival after cabg
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914357/
https://www.ncbi.nlm.nih.gov/pubmed/24447406
http://dx.doi.org/10.1186/1475-2840-13-25
work_keys_str_mv AT hallbergville associationsofmetabolicsyndromeanddiabetesmellituswith16yearsurvivalaftercabg
AT palomakiari associationsofmetabolicsyndromeanddiabetesmellituswith16yearsurvivalaftercabg
AT lahtelajorma associationsofmetabolicsyndromeanddiabetesmellituswith16yearsurvivalaftercabg
AT voutilainenseppo associationsofmetabolicsyndromeanddiabetesmellituswith16yearsurvivalaftercabg
AT tarkkamatti associationsofmetabolicsyndromeanddiabetesmellituswith16yearsurvivalaftercabg
AT katajamatti associationsofmetabolicsyndromeanddiabetesmellituswith16yearsurvivalaftercabg